|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 5.020 USD | -2.71% |
|
+7.73% | -22.29% |
| 08-12 | Aquestive Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-11 | Aquestive Therapeutics Q2 Loss Widens, Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 630M | - | ||||
| 1,047B | |||||
| 646B | - | - | - | ||
| 451B | |||||
| 355B | |||||
| 291B |
Select your edition
All financial news and data tailored to specific country editions
